Shareholder Alert: The Ademi Firm Investigates Whether Core Scientific, Inc. Is Obtaining a Fair Price for Its Public Shareholders

MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating Core Scientific (NYSE: CORZ) for possible breaches of fiduciary duty and other violations of law in its transaction with CoreWeave.

Click here to learn how to join our investigation and obtain additional information or contact us at [e-mail] or toll-free: 866-264-3995. There is no cost or obligation to you.

In the transaction, shareholders of Core Scientific will receive 0.1235 newly issued shares of CoreWeave Class A common stock for each Core Scientific share they own in an all-stock transaction valued at approximately $9.0 billion. Core Scientific insiders will receive substantial benefits as part of change of control arrangements.

The transaction agreement unreasonably limits competing transactions for Core Scientific by imposing a significant penalty if Core Scientific accepts a competing bid. We are investigating the conduct of the Core Scientific board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.

We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.